These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36380972)

  • 1. Interleukin-33 and Soluble ST2 as Potential Biomarkers of Cancer in Opium Users: A Nested Case-Control Study.
    Firouzabadi N; Javdani K; Dehshahri A
    Iran J Med Sci; 2022 Nov; 47(6):541-548. PubMed ID: 36380972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum soluble ST2 is associated with ER-positive breast cancer.
    Lu DP; Zhou XY; Yao LT; Liu CG; Ma W; Jin F; Wu YF
    BMC Cancer; 2014 Mar; 14():198. PubMed ID: 24636276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-33 and Soluble ST2 Levels in Infants with Hypoxic-Ischemic Encephalopathy.
    Hamano H; Takahashi K; Kimura S; Matsuguma C; Kaneyasu H; Fujimoto Y; Ohta N; Okada S; Hasegawa S
    Neonatology; 2023; 120(3):353-362. PubMed ID: 36996771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans.
    Pusceddu I; Dieplinger B; Mueller T
    Clin Chim Acta; 2019 Aug; 495():493-500. PubMed ID: 31136737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of serum interleukin-33 and soluble suppression of tumorigenicity 2 (sST2) receptors in patients with and without periodontal disease.
    Singh H; Singh A; Saluja R
    Indian J Dent Res; 2022; 33(1):37-40. PubMed ID: 35946242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High plasma sST2 levels in gastric cancer and their association with metastatic disease.
    Bergis D; Kassis V; Radeke HH
    Cancer Biomark; 2016; 16(1):117-25. PubMed ID: 26835712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting value of serum soluble ST2 and interleukin-33 for risk stratification and prognosis in patients with acute myocardial infarction.
    Zhang K; Zhang XC; Mi YH; Liu J
    Chin Med J (Engl); 2013; 126(19):3628-31. PubMed ID: 24112154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of interleukin-33, soluble ST2 and IgE in patients with asthma: a case-control study.
    Singh H; Khurana A; Kumar A; Saluja R
    J Asthma; 2024 Jan; 61(1):48-57. PubMed ID: 37548422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum levels of IL-33 and soluble ST2 in neonates with human cytomegalovirus infection.
    Chen Y; Qian J
    J Med Virol; 2018 Aug; 90(8):1383-1388. PubMed ID: 29663450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum soluble ST2 is a promising prognostic biomarker in HBV-related acute-on-chronic liver failure.
    Jiang SW; Wang P; Xiang XG; Mo RD; Lin LY; Bao SS; Lu J; Xie Q
    Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):181-188. PubMed ID: 28381383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Soluble ST2 Levels Are Higher in Neurodegenerative Disorders and Associated with Poorer Cognition.
    Tan YJ; Siow I; Saffari SE; Ting SKS; Li Z; Kandiah N; Tan LCS; Tan EK; Ng ASL
    J Alzheimers Dis; 2023; 92(2):573-580. PubMed ID: 36776067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ST2 Signaling in the Tumor Microenvironment.
    Chang CP; Hu MH; Hsiao YP; Wang YC
    Adv Exp Med Biol; 2020; 1240():83-93. PubMed ID: 32060890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum soluble suppression of tumorigenicity 2 as a novel inflammatory marker predicts the severity of acute pancreatitis.
    Zhang Y; Cheng B; Wu ZW; Cui ZC; Song YD; Chen SY; Liu YN; Zhu CJ
    World J Gastroenterol; 2021 Oct; 27(38):6489-6500. PubMed ID: 34720537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-33 and Its Receptor ST2 after Inhaled Allergen Challenge in Allergic Asthmatics.
    Mitchell PD; Salter BM; Oliveria JP; El-Gammal A; Tworek D; Smith SG; Sehmi R; Gauvreau GM; O Apos Byrne PM
    Int Arch Allergy Immunol; 2018; 176(2):133-142. PubMed ID: 29694974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of the IL-33-sST2 pathway in hypertensive patients and a mouse model.
    Yin X; Cao H; Wei Y; Li HH
    Hypertens Res; 2019 Nov; 42(11):1664-1671. PubMed ID: 31235844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic value of combining serum soluble ST2 and interleukin-33 for heart failure patients with preserved left ventricular ejection fraction].
    Luo NS; Zhang HF; Liu PM; Lin YQ; Huang TC; Yang Y; Wang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Mar; 45(3):198-203. PubMed ID: 28316175
    [No Abstract]   [Full Text] [Related]  

  • 17. Soluble ST2: A complex and diverse role in several diseases.
    Homsak E; Gruson D
    Clin Chim Acta; 2020 Aug; 507():75-87. PubMed ID: 32305537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model.
    Takenaga K; Akimoto M; Koshikawa N; Nagase H
    PLoS One; 2020; 15(4):e0232230. PubMed ID: 32340025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevations in Circulating sST2 Levels Are Associated With In-Hospital Mortality and Adverse Clinical Outcomes After Blunt Trauma.
    Billiar IM; Guardado J; Abdul-Malak O; Vodovotz Y; Billiar TR; Namas RA
    J Surg Res; 2019 Dec; 244():23-33. PubMed ID: 31279260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of soluble ST2, but not IL-33, correlate with the severity of alcoholic liver disease.
    Sun Z; Chang B; Huang A; Hao S; Gao M; Sun Y; Shi M; Jin L; Zhang W; Zhao J; Teng G; Han L; Tian H; Liang Q; Zhang JY; Zou Z
    J Cell Mol Med; 2019 Feb; 23(2):887-897. PubMed ID: 30478965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.